Listen to the Joystiq Podcast (because your ears can't read)

Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!

Damning FDA report confirms Avandia risks

The beleaguered US Food and Drug Administration (FDA) today released its review of the Avandia debacle. It contains a fairly damning assessment of what went wrong, one that implicates not only Avandia's manufacturer GlaxoSmithKline, but also the FDA itself.

The 436-page review confirms that Avandia does indeed increase the risk of heart problems, a claim that Glaxo has vigorously denied. (Can't wait to see how they respond to this.) The FDA reviewers concluded that the risk is also far greater than that posed by a similar drug, Actos, which is manufactured by Takeda. In addition, the FDA reviewers were dismissive of the studies conducted by Glaxo - studies that the drugmaker claimed provided proof of Avandia's safety. The report also restates the allegation that Glaxo tried to coerce a doctor into remaining silent about the risks posed to diabetics from taking Avandia.

The report goes on to find fault with the FDA's inaction and, by implication, its completely pathetic pandering to Glaxo. Now, even insiders are publicly saying FDA officials repeatedly put the interests of Glaxo above the interests, health and safety of consumers.

All-in-all, this represents a big victory for Glaxo/BigPharma's critics. It almost goes without saying that this report likely marks the end of the line for Avandia. Perhaps more significant could be the impact of the whole mess on the FDA. The review effectively highlights the shortcomings of the agency for all to see, greatly strengthening the hand of its critics - both in and outside government - who are calling for major reforms there.

Click here to read more.

Stay tuned for news of the advisory committee hearing on Avandia, which is scheduled to be held Monday.

Reader Comments

(Page 1)
Features
Form and Function (12)
Retro Review (7)
Media
Personalities (38)
Blogs (21)
Books (24)
Products (129)
Services (43)
Magazines (12)
Meet the Bloggers
Bloggers (5)
Diane Rixon (1)
Chris Sparling (1)
Allie Beatty (38)
News
Daily News (180)
Events (63)
Fundraisers (23)
Opinion (114)
Prevention
Diet (366)
Exercise (97)
Lifestyle (512)
Research (465)
Treatment
Care (63)
Complications (37)
Drugs (384)
Support (235)
Types of Diabetes
Adult Onset (517)
Childhood (447)
Type 1 (791)
Type 2 (987)

RESOURCES

RSS NEWSFEEDS

Powered by Blogsmith

Other Weblogs Inc. Network blogs you might be interested in: